← Back to Search
Inhibition Of Hypoxia-inducible Factor (HIF) Hydroxylases By Citric Acid Cycle Intermediates
P. Koivunen, Maija Hirsilä, A. Remes, I. Hassinen, K. Kivirikko, J. Myllyharju
Published 2007 · Biology, Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
The stability and transcriptional activity of the hypoxia-inducible factors (HIFs) are regulated by two oxygen-dependent events that are catalyzed by three HIF prolyl 4-hydroxylases (HIF-P4Hs) and one HIF asparaginyl hydroxylase (FIH). We have studied possible links between metabolic pathways and HIF hydroxylases by analyzing the abilities of citric acid cycle intermediates to inhibit purified human HIF-P4Hs and FIH. Fumarate and succinate were identified as in vitro inhibitors of all three HIF-P4Hs, fumarate having Ki values of 50–80 μm and succinate 350–460 μm, whereas neither inhibited FIH. Oxaloacetate was an additional inhibitor of all three HIF-P4Hs with Ki values of 400–1000 μm and citrate of HIF-P4H-3, citrate being the most effective inhibitor of FIH with a Ki of 110 μm. Culturing of cells with fumarate diethyl or dimethyl ester, or a high concentration of monoethyl ester, stabilized HIF-1α and increased production of vascular endothelial growth factor and erythropoietin. Similar, although much smaller, changes were found in cultured fibroblasts from a patient with fumarate hydratase (FH) deficiency and upon silencing FH using small interfering RNA. No such effects were seen upon culturing of cells with succinate diethyl or dimethyl ester. As FIH was not inhibited by fumarate, our data indicate that the transcriptional activity of HIF is quite high even when binding of the coactivator p300 is prevented. Our data also support recent suggestions that the increased fumarate and succinate levels present in the FH and succinate dehydrogenase-deficient tumors, respectively, can inhibit the HIF-P4Hs with consequent stabilization of HIF-αs and effects on tumor pathology.
This paper references
 Assays of intermediates of the citric acid cycle and related compounds by fluorometric enzyme methods
J. Williamson (1969)
Mechanism of the prolyl hydroxylase reaction. 1. Role of co-substrates.
L. Tuderman (1977)
The 2-oxoglutarate binding site of prolyl 4-hydroxylase. Identification of distinct subsites and evidence for 2-oxoglutarate decarboxylation in a ligand reaction at the enzyme-bound ferrous ion.
K. Majamaa (1984)
Reduction of collagen production in keloid fibroblast cultures by ethyl-3,4-dihydroxybenzoate. Inhibition of prolyl hydroxylase activity as a mechanism of action.
T. Sasaki (1987)
Inhibition of prolyl hydroxylation and procollagen processing in chick-embryo calvaria by a derivative of pyridine-2,4-dicarboxylate. Characterization of the diethyl ester as a proinhibitor.
G. Tschank (1991)
Characterization of the human prolyl 4-hydroxylase tetramer and its multifunctional protein disulfide-isomerase subunit synthesized in a baculovirus expression system.
K. Vuori (1992)
Characterization of the iron‐ and 2‐oxoglutarate‐binding sites of human prolyl 4‐hydroxylase
J. Myllyharju (1997)
Inhibition of HIF Prolyl 4-Hydroxylases 4532 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME
J. Myllyharju (1997)
Effects of hypobaric hypoxia on vascular endothelial growth factor and the acute phase response in subjects who are susceptible to high-altitude pulmonary oedema
V. Pavlíček (2000)
The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.
A. Gimenez-Roqueplo (2001)
Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation
Panu Jaakkola (2001)
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing
M. Ivan (2001)
C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation
A. C. Epstein (2001)
HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation
F. Yu (2001)
A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF
R. Bruick (2001)
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
Sonny O. Ang (2002)
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
David Lando (2002)
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor
M. Ivan (2002)
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
I. Tomlinson (2002)
Hypoxia-inducible Factor (HIF) Asparagine Hydroxylase Is Identical to Factor Inhibiting HIF (FIH) and Is Related to the Cupin Structural Family*
K. Hewitson (2002)
FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor.
David Lando (2002)
A role for mitochondrial enzymes in inherited neoplasia and beyond
C. Eng (2003)
Targeting HIF-1 for cancer therapy
G. Semenza (2003)
On the association of succinate dehydrogenase mutations with hereditary paraganglioma
B. Baysal (2003)
Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis.
J. Myllyharju (2003)
The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer.
W. Kim (2003)
Characterization of the Human Prolyl 4-Hydroxylases That Modify the Hypoxia-inducible Factor*
M. Hirsilä (2003)
HCaRG is a novel regulator of renal epithelial cell growth and differentiation causing G2M arrest.
A. M. Devlin (2003)
HIF prolyl‐hydroxylase 2 is the key oxygen sensor setting low steady‐state levels of HIF‐1α in normoxia
E. Berra (2003)
Oxygen sensing by HIF hydroxylases
C. Schofield (2004)
Catalytic Properties of the Asparaginyl Hydroxylase (FIH) in the Oxygen Sensing Pathway Are Distinct from Those of Its Prolyl 4-Hydroxylases*
P. Koivunen (2004)
Differentiating the functional role of hypoxia‐inducible factor (HIF)‐1α and HIF‐2α (EPAS‐1) by the use of RNA interference: erythropoietin is a HIF‐2α target gene in Hep3B and Kelly cells
C. Warnecke (2004)
A novel mutation of the fumarase gene in a family with autosomal recessive fumarase deficiency
A. Remes (2004)
Determination and comparison of specific activity of the HIF‐prolyl hydroxylases
J. Tuckerman (2004)
Progressive muscular dystrophy (Duchenne): Biochemical studies by flow-cytometry
M. Hirsch-Kauffmann (2004)
Endogenous 2-oxoacids differentially regulate expression of oxygen sensors.
C. Dalgard (2004)
Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor*
R. Appelhoff (2004)
Collagens, modifying enzymes and their mutations in humans, flies and worms.
J. Myllyharju (2004)
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.
P. Pollard (2005)
Proline hydroxylation and gene expression.
W. Kaelin (2005)
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability.
J. Isaacs (2005)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
M. Selak (2005)
Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway
M. Hirsilä (2005)
Reversible Inactivation of HIF-1 Prolyl Hydroxylases Allows Cell Metabolism to Control Basal HIF-1*
H. Lu (2005)
This paper is referenced by
Mitochondrial metabolism regulates macrophage biology
Yafang Wang (2021)
Proline dehydrogenase in cancer: apoptosis, autophagy, nutrient dependency and cancer therapy.
Yating Liu (2021)
Cancer metabolism and intervention therapy
Huakan Zhao (2021)
The non-canonical functions of HIF prolyl hydroxylases and their dual roles in cancer.
Mengchao Yu (2021)
From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy
Emanuela Di Gregorio (2021)
EGFR-HIF1α signaling positively regulates the differentiation of IL-9 producing T helper cells
Suyasha Roy (2021)
The impact of mitochondria on cancer treatment resistance.
M. van der Merwe (2021)
Targeting alveolar‐specific succinate dehydrogenase A attenuates pulmonary inflammation during acute lung injury
C. Vohwinkel (2021)
Hypoxia-Inducible Factor-1α (HIF-1α) Inhibition Impairs Retinoic Acid-Induced Differentiation in SH-SY5Y Neuroblastoma Cells, Leading to Reduced Neurite Length and Diminished Gene Expression Related to Cell Differentiation.
Pedro Ozorio Brum (2021)
Complete Response of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)-Associated Renal Cell Carcinoma to Pembrolizumab Immunotherapy: A Case Report
Tao Wang (2021)
Crosstalk in oxygen homeostasis networks: SKN-1/NRF inhibits the HIF-1 hypoxia-inducible factor in Caenorhabditis elegans
Dingxia Feng (2021)
Development of a colorimetric α-ketoglutarate detection assay for prolyl hydroxylase domain (PHD) proteins
Samantha J. Wong (2021)
Cocaine potentiates an inflammatory response in C6 astroglia-like cells
Maryam Agharahimi (2021)
α-Tocopherol Acetate Attenuates Mitochondrial Oxygen Consumption and Maintains Primitive Cells within Mesenchymal Stromal Cell Population.
D. Loncaric (2021)
The role of HIF proteins in maintaining the metabolic health of the intervertebral disc
Elizabeth S. Silagi (2021)
Succinate receptor 1 inhibits mitochondrial respiration in cancer cells addicted to glutamine.
The anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunity.
G. Cavalli (2021)
BNIP3 promotes HIF‐1α‐driven melanoma growth by curbing intracellular iron homeostasis
Mónica Vara-Pérez (2021)
The epigenetic and morphogenetic effects of molecular oxygen and its derived reactive species in development.
M. J. Hitchler (2021)
A chemical screen for suppressors of dioxygenase inhibition in a yeast model of familial paraganglioma
William Beimers (2021)
Tricarboxylic Acid (TCA) Cycle Intermediates: Regulators of Immune Responses
Inseo Choi (2021)
α‐ketoglutarate delays age‐related fertility decline in mammals
Zhenzhen Zhang (2021)
Regulatory T cell differentiation is controlled by αKG-induced alterations in mitochondrial metabolism and lipid homeostasis.
Maria I. Matias (2021)
Hypoxia Inducible Factors as Central Players in the Pathogenesis and Pathophysiology of Cardiovascular Diseases
Emilio Y. Lucero García Rojas (2021)
Polarization of Macrophages in Insects: Opening Gates for Immuno-Metabolic Research
Adam Bajgar (2021)
The Macrophage Response Is Driven by Mesenchymal Stem Cell-Mediated Metabolic Reprogramming
N. Luque-Campos (2021)
Involvement of Tricarboxylic Acid Cycle Metabolites in Kidney Diseases
Alexis Paulina Jiménez-Uribe (2021)
Redox Signaling from Mitochondria: Signal Propagation and Its Targets
P. Ježek (2020)
Hypoxia Inducible Factor-1α in Osteochondral Tissue Engineering
Dheraj K Taheem (2020)
Heat acclimation mediated cardioprotection is controlled by mitochondrial metabolic remodeling involving HIF-1α.
A. Mreisat (2020)
Neuroinflammatory inhibition of synaptic long‐term potentiation requires immunometabolic reprogramming of microglia
E. York (2020)
Structural basis for GPCR signaling by small polar versus large lipid metabolites-discovery of non-metabolite ligands.
Michael Lückmann (2020)See more